US 8734799
Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer
granted A61KA61K2039/505A61P
Quick answer
US patent 8734799 (Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer) held by The Regents of the University of California expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00